Aspen Aerogels (NYSE:ASPN) Releases Q1 2026 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) updated its first quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of -0.280–0.240 for the period, compared to the consensus EPS estimate of -0.220. The company issued revenue guidance of $35.0 million-$40.0 million, compared to the consensus revenue estimate of $44.3 million.

Analysts Set New Price Targets

ASPN has been the topic of a number of recent analyst reports. Canaccord Genuity Group reduced their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Roth Mkm lowered their target price on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating for the company in a research note on Thursday. Finally, TD Cowen reduced their price target on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Aspen Aerogels has a consensus rating of “Hold” and an average target price of $4.50.

Aspen Aerogels Stock Down 4.9%

NYSE ASPN traded down $0.16 during trading hours on Friday, reaching $2.99. 1,008,261 shares of the company’s stock were exchanged, compared to its average volume of 1,597,496. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94. The company has a market capitalization of $246.70 million, a price-to-earnings ratio of -0.63 and a beta of 2.99. The company’s 50-day moving average is $3.32 and its two-hundred day moving average is $5.07. Aspen Aerogels has a one year low of $2.30 and a one year high of $9.78.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The company had revenue of $41.34 million during the quarter, compared to the consensus estimate of $44.25 million. Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The company’s revenue was down 66.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, analysts forecast that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Invesco Ltd. boosted its position in Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after purchasing an additional 2,907,558 shares during the period. XTX Topco Ltd raised its position in shares of Aspen Aerogels by 786.1% in the fourth quarter. XTX Topco Ltd now owns 202,030 shares of the construction company’s stock valued at $572,000 after purchasing an additional 179,231 shares during the period. Quadrature Capital Ltd lifted its stake in shares of Aspen Aerogels by 248.5% during the 4th quarter. Quadrature Capital Ltd now owns 35,583 shares of the construction company’s stock worth $101,000 after buying an additional 25,373 shares during the last quarter. Numerai GP LLC boosted its holdings in shares of Aspen Aerogels by 1,277.9% during the 4th quarter. Numerai GP LLC now owns 251,888 shares of the construction company’s stock worth $713,000 after buying an additional 233,608 shares during the period. Finally, Oxford Asset Management LLP acquired a new position in Aspen Aerogels in the 4th quarter valued at about $68,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.